Man Group PLC Corcept Therapeutics Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Man Group PLC holds 350,533 shares of CORT stock, worth $20.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

350,533

Previous 829,943 57.76%

Holding current value

$20.9 Million

Previous $27 Million 39.86%

% of portfolio

0.05%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $14.1 Million - $22.2 Million	-479,410 Reduced 57.76%	350,533 $16.2 Million
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $14.9 Million - $23.1 Million	-668,977 Reduced 44.63%	829,943 $27 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $14.2 Million - $18.5 Million	672,819 Added 81.45%	1,498,920 $37.8 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $5.47 Million - $7.25 Million	220,358 Added 36.38%	826,101 $26.8 Million
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $223,698 - $344,151	-10,182 Reduced 1.65%	605,743 $16.5 Million
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $944,860 - $1.11 Million	-44,070 Reduced 6.68%	615,925 $13.7 Million
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $487,507 - $621,317	-25,391 Reduced 3.7%	659,995 $14.3 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $1.26 Million - $1.89 Million	-63,015 Reduced 8.42%	685,386 $13.9 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $8.82 Million - $10.4 Million	-357,031 Reduced 32.3%	748,401 $19.2 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $11.4 Million - $16.7 Million	659,692 Added 148.0%	1,105,432 $26.3 Million
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $77,261 - $117,831	-4,674 Reduced 1.04%	445,740 $10 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $727,587 - $993,093	42,549 Added 10.43%	450,414 $8.92 Million
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $685,218 - $784,449	34,818 Added 9.33%	407,865 $8.03 Million
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $1.68 Million - $2.06 Million	84,292 Added 29.19%	373,047 $8.21 Million
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $882,636 - $1.15 Million	-37,575 Reduced 11.51%	288,755 $6.87 Million
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $7.55 Million - $12.3 Million	-449,798 Reduced 57.95%	326,330 $8.54 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $3.55 Million - $5.7 Million	285,174 Added 58.09%	776,128 $13.5 Million
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $2.87 Million - $4.76 Million	-260,753 Reduced 34.69%	490,954 $8.26 Million
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $1.58 Million - $2.19 Million	155,912 Added 26.17%	751,707 $8.94 Million
Q4 2019 Feb 18, 2020	BUY	$12.06 - $16.96 $4.52 Million - $6.36 Million	375,033 Added 169.88%	595,795 $7.21 Million
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $461,246 - $649,555	44,308 Added 25.11%	220,762 $3.12 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $2.56 Million - $3.33 Million	-261,363 Reduced 59.7%	176,454 $1.97 Million
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $1.46 Million - $2.29 Million	146,048 Added 50.06%	437,817 $5.14 Million
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $2.02 Million - $3.07 Million	-178,623 Reduced 37.97%	291,769 $3.9 Million
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $4.12 Million - $5.25 Million	335,409 Added 248.48%	470,392 $6.6 Million
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $836,145 - $1.08 Million	-54,650 Reduced 28.82%	134,983 $2.12 Million
Q1 2018 May 15, 2018	BUY	$14.59 - $25.5 $2.77 Million - $4.84 Million	189,633 New	189,633 $3.12 Million

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.39B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account